Matching adjusted indirect comparison of PFS & OS comparing ribociclib plus letrozole vs palbociclib plus letrozole as first-line treatment of HR+/HER2-ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2 - Jhaveri, K.; O'Shaughnessy, J.; Fasching, Peter; Cardoso, F.; Tolaney, S.; Hamilton, E.; Sharma, V. K.; Biswas, C.; Haftchenary, S.; Pathak, P.; Rugo, H. (EUROPEAN JOURNAL OF CANCER, 2022)
CRIS-Team WoS Importer:2023-03-10